University of California San Francisco
Give to UCSF
More than twice as many people experiencing homelessness in San Francisco died during the first year of the COVID-19 pandemic compared to previous years, with the leading cause of death being drug overdose. No deaths were attributed to the virus itself.
55% of seniors with dementia take more than six medications even though most have good health. However, a UCSF study showed that 87% are willing to cut down if their doctors agree.
UCSF researchers successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.
Using AI in ECG analysis improves diagnosis, treatment and monitoring of hypertrophic cardiomyopathy, a leading cause of sudden death in adolescents.
Mark Moasser, MD, has sorted out why HER2, the protein driving 1 in 5 breast cancers, is so hard to drug. He explains how the findings correct a naive way of envisioning how HER2 is shaped and how it works.
When women's health researchers analyzed Medi-Cal data to see how two long-term contraceptives performed in the real world, they were surprised to find IUDs work at least as well as tubal ligation, while causing fewer side effects.
Concussion may have a long-term impact on cognition, a new UCSF-led study finds. Fourteen percent of patients had "poor cognitive outcome" one year post injury, with car collisions being the leading cause of concussion.
In medical school, Nathan Lo thought we could do more to help the 750 million people around the world with or at risk of getting schistosomiasis. This week, he helped World Health Organization rewrite guidelines to treat everyone in affected communities.
A new fast-track review for UCSF gene therapy could help more kids with deadly Artemis-SCID disease get life-saving treatment sooner.
Using data from over 100,000 malignant and non-malignant cells from 15 human brain metastases, UCSF researchers have revealed two functional archetypes of metastatic cells across 7 different types of brain tumors, each containing both immune and non-immune cell types.
UCSF researchers have developed a digital tool to flag early reading challenges that may lead to dyslexia, and it could be in widespread use in California public schools by 2023. Governor Gavin Newsom is proposing $10 million in the state budget for the project.
A UCSF-led study found a new drug for ALS that shows to slow or temporarily stall the progression of ALS in a select group of patients, with three times as many patients' disease slowing compared to those who received a placebo.
A new “atlas” of every cell in the brain’s blood vessels reveals that some strokes are caused by immune cells interacting with arteries, in a new study by UCSF researchers.
A collaborative study between UCSF researchers discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation.
UCSF researchers used multiple drug analogs to test CSF1R inhibition in transgenic mice with tauopathy, and observed suppressed biomarkers of neurodegeneration, rescued aberrant behavior, and extended survival in female mice.
Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.
In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.
Binge drinking can lead to more ER visits and first episodes of a serious heart condition, new UCSF study reports.
Human vocal sounds have the same rhythmic quality as the sounds made by many mammals, songbirds, and even some species of fish. UCSF researchers have found the brainstem circuit responsible, and it's connected breath control.
UCSF researchers show how physical activity protects cognition by altering brain chemistry that maintains synapses, especially for the elderly.
UCSF researchers found that cancers from different parts of the body are immunologically similar to one another. They described 12 classes of "immune archetypes" to classify cancer tumors, which can provide unique strategies for enhancing patients’ choice of cancer immunotherapies.
Brain maps and developmental outcomes differ greatly in newborns with two of the most common brain injury types, which may have implications for early intervention.
A new study led by scientists at UCSF's Quantitative Biosciences Institute and University College London found that the Alpha variant of SARS-CoV-2 ramped up production of a protein that it uses to stifle infected cells’ immune-stimulating signals, helping it evade immune detection and accelerate its transmission.
There is some information that is known about the variant and other information that sti
